Urothelial carcinoma in kidney transplant recipients: conversion from calcineurin inhibitor to proliferation signal inhibitor?
Chung
Shiu-Dong
SD
Lai
Ming-Kuen
MK
Wang
Shuo-Meng
SM
Liao
Chun-Hou
CH
Yu
Hong-Jeng
HJ
Chueh
Shih-Chieh
SC
D065095:Calcineurin Inhibitors; D049109:Cell Proliferation; D016572:Cyclosporine / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000009:adverse effects*; D011182:Postoperative Care; D015398:Signal Transduction / Q000187:drug effects*; D020123:Sirolimus / Q000627:therapeutic use; D001749:Urinary Bladder Neoplasms / Q000209:etiology* / Q000517:prevention & control
D065095:Calcineurin Inhibitors; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D020123:Sirolimus